XENE

Xenon Pharmaceuticals Inc.

Price

$60.45

return (12m)

53.80%

p/e

-14.66

p/bv

4.83

DIVIDEND YIELD

0.00%

XENE price

Xenon Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment XENE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.92%

3 months

14.07%

1 year

53.80%

2 years

49.84%

5 years

232.12%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals XENE

Valuation

P/E

-14.66

Sector -4.23

Industry -4.23

P/BV

4.83

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.05

Industry 2.05

EV/EBITDA

-41.32

Sector -546.75

Industry -546.75

EV/EBIT

-41.14

Sector -37.85

Industry -37.85

P/EBITDA

-13.65

Sector -51.33

Industry -51.33

P/EBIT

-13.58

Sector -39.56

Industry -39.56

P/Total Assets

4.63

Sector 1.25

Industry 1.25

P/Net Current Assets

6.72

Sector -5.36

Industry -5.36

P/Working Capital

6.66

Sector -1.24

Industry -1.24

EPS

-4.09

Sector -1.92

Industry -1.92

BVPS

12.42

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

0.00%

Sector 39.10%

Industry 39.10%

EBITDA Margin

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

0.00%

Sector -36.62%

Industry -36.62%

Net Profit Margins

0.00%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-32.94%

Sector -60.49%

Industry -60.49%

ROA

-31.58%

Sector -63.06%

Industry -63.06%

ROIC

-150.39%

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

21.01

Sector 2.90

Industry 2.90

Net Debt / EBITDA

7.59

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

7.56

Sector -10.24

Industry -10.24

Net Debt / Equity

-0.75

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.96

Sector 0.43

Industry 0.43

Liabilities/Assets

0.04

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

38.99%

Sector -

Industry -

Fundamentals XENE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
XENE Xenon Pharmaceuticals Inc.	$60.45	53.80%	0.00%	-14.66	4.83	-32.94%	0.00%
JNJ Johnson & Johnson	$277.82	60.73%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.67	22.83%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$260.84	27.01%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-12.95%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$151.13	83.70%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$164.27	2.46%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.65	49.46%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$75.60	-49.60%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$443.34	60.06%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$841.88	49.91%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.11	50.14%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$920.40	33.76%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$557.35	38.99%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$247.26	67.44%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$42.74	15.20%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,061.23	50.23%	0.00%	3.11	3.48	112.18%	44.41%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XENE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Xenon Pharmaceuticals

Xenon Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

30 years

Founded: 1996

2014

Time since IPO - 12 years

129

Employees

Xenon Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $6.00 billion, with shareholders equity totaling $1.24 billion.

The company employs approximately 129 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Xenon Pharmaceuticals Inc. reported $- in revenue, generating net income of $-409.20 million.

Key financial metrics include a P/E ratio of -14.66, a price-to-book (P/B) ratio of 4.83, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker XENE.

Market cap

$6.00 billion

Net worth

$1.24 billion

$1,242,400,000.00

Assets

$1.30 billion

$1,295,770,000.00

Total Shares Outstanding

100.00 million

100,000,000

Average Daily Trading Volume

$1.20 million

$1,202,860.00

Sector

Health Care

Industry

Biotechnology

XENE

XENE revenue and profits

Financial Results XENE

DRAG THE FRAME TO SEE MORE DATA

XENE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$920.40 33,91% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$247.26 66,32% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$260.84 27,05% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$151.13 86,53% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$164.27 2,88% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.67 23,78% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$920.40 33,91% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$247.26 66,32% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$260.84 27,05% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$151.13 86,53% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$164.27 2,88% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.67 23,78% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Xenon Pharmaceuticals (XENE) today?

A cotação de Xenon Pharmaceuticals (XENE) hoje está em US$ 60.45, com uma variação de 53.8% em relação ao último ano. A cotação de Xenon Pharmaceuticals (XENE) iniciou o ano negociando na casa dos US$ 44.82 e hoje está em US$ 60.45. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Xenon Pharmaceuticals (XENE) e dados de ações do Ibovespa e mercados internacionais.

Quando Xenon Pharmaceuticals (XENE) paga dividendos?

Xenon Pharmaceuticals (XENE) não distribuiu dividendos no último ano.

Is Xenon Pharmaceuticals (XENE) a good investment?

Atualmente, Xenon Pharmaceuticals (XENE) está cotada a US$ 60.45, com um P/L de -14.66, representando um desvio de -1,523% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 53.8 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 53.80%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Xenon Pharmaceuticals (XENE) stock?

Investir em ações de Xenon Pharmaceuticals (XENE) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Xenon Pharmaceuticals (XENE) yield today?

A rentabilidade de Xenon Pharmaceuticals (XENE) foi de -2.92% no último mês, 53.80% no último ano e 232.12% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Xenon Pharmaceuticals (XENE) hoje, o investimento total seria de US$ 6,044.50, com base na cotação atual de US$ 60.45.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 9,296.44
Em 5 anos: US$ 20,074.99
Em 10 anos: US$ 6,044.50

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

XENE

Xenon Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment XENE

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING XENE WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Xenon Pharmaceuticals

Xenon Pharmaceuticals Inc.

United States

30 years

2014

129

PROFIT X PRICE XENE

Financial Results XENE

XENE cash flow

Asset, Revenue and Profit Growth - XENE

XENE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions